Trinity Biotech | TRIB - Assets


Trinity Biotech reported $103.71M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Bio-Rad Laboratories USD 9.7B 517.7M Sep/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
J&J USD 192.82B 573M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Siemens EUR 166.2B 3.75B Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Tosoh JPY 1.34T 44.3B Dec/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025
Veracyte USD 1.37B 23.68M Sep/2025